Trials / Completed
CompletedNCT01285544
The Efficacy and Tolerability of Two Formulations of Atorvastatin In Korean Adult With Hypercholesterolemia
Assessment of the Efficacy and Tolerability of Two Formulations of Atorvastatin In Korean Adult With Hypercholesterolemia : A Multicenter, Prospective, Open-Label, Randomized, Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 289 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
There will be no significant differences in the efficacy and tolerability between the test and reference formulations of atorvastatin 20 mg in these Korean adults with primary hypercholesterolemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atorvastatin (Lipinon) | treatment of dyslipidemia administration : PO, qod |
| DRUG | Atorvastatin (Lipitor) | treatment of dyslipidemia administration : PO, qod |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2009-07-01
- Completion
- 2009-07-01
- First posted
- 2011-01-28
- Last updated
- 2013-12-17
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01285544. Inclusion in this directory is not an endorsement.